Cervical cancer prevention: Human papillomavirus testing as primary screening

Low‐ and middle‐income countries carry a high burden of preventable cervical cancer cases and deaths. Because human papillomavirus DNA‐based testing is increasingly becoming the preferred method of screening for cervical cancer prevention, this commentary discusses next steps and key considerations for its expansion.